Prime Highlights
- SheMed raised $50 million at a $1 billion valuation after building a women-focused telehealth platform for GLP-1 treatment support.
- The startup was recognised in this year’s Europe 30 Under 30 Science and Healthcare list.
Key Facts
- SheMed has served more than 80,000 patients through its telehealth platform.
- The company was founded by sisters Olivia and Chloe Ferro in 2024.
Background
The London-based women’s health startup SheMed has become one of the most important healthcare businesses, which this year appears on the Europe 30 Under 30 Science and Healthcare list because it shows how young business leaders are changing how people receive medical care.
Sisters Olivia Ferro and Chloe Ferro established SheMed in 2024 to operate a telehealth platform that provides healthcare services exclusively to women. The company delivers treatment guidance and medication management services to patients instead of issuing just medication prescriptions. SheMed has already served more than 80,000 patients.
The startup gained strong investor backing in October after raising $50 million at a valuation of $1 billion. Its founders launched the company after Olivia Ferro faced years of undiagnosed health issues before eventually receiving treatment for polycystic ovarian syndrome. She said her medical concerns were often dismissed before she received proper care, which inspired the sisters to build a platform focused on women’s health needs.
The annual Europe 30 Under 30 Science and Healthcare list recognizes young founders, scientists and innovators under the age of 30 who are advancing healthcare and science across the region.
Several other startups were also recognised for using technology to improve healthcare access and diagnosis. These include firms working in neurology, mental health, cancer diagnostics, prosthetics and emergency care.
Industry experts say this year’s list reflects growing innovation across Europe’s healthcare sector, with founders increasingly using artificial intelligence and medical technology to solve treatment gaps, improve diagnosis and expand access to care.
